ARCHIVES

FDA Approives Lilly’s Alimta For 1st-Line Metastatic NSCLC

This article is from The Cancer Letter archive.

Vol. 31 No. 9 | September 26, 2008

Download PDF Visit The Full Archive

Related Articles

UCLA Comp Center status Near, But There Are Problems

October 22, 1976

DCT Get Okay to Proceed With Human Cell Line Drug Screening, More Drug Discovery Group

June 19, 1987

NCI Programs: Institute To Develop Plans For Large Trial Of Spiral CT Scanning For Lung Cancer

November 5, 1999

DCCP Board Approves Concepts For Nearly $20 Million In Grants, Contracts, Including New Inhibitors Study

June 10, 1983

NCI Suspend Tulane, LSU From Accrual Due To Missing Data

April 29, 1994

ACS Board Accepts Hammer’s ffer, Will Support Construction Survey

February 17, 1984